Estradiol-Inducible Squelching and Cell Growth Arrest by a Chimeric VP16-Estrogen Receptor Expressed in Saccharomyces cerevisiae: Suppression by an allele of PDR1

REFERENCES

• Ali, S., Y. Lutz, J. P. Belloq, and D. Metzger. Unpublished data.
   Google Scholar
• Bach, Μ. L., F. Lacroute, and D. Botstein. 1979. Evidence for transcriptional regulation of orotidine-5' -phosphate decarboxylase in yeast by hybridization of mRNA to the yeast structural gene in Escherichia coli. Proc. Natl. Acad. Sci. USA 76:386–390.
   PubMedGoogle Scholar
• Balzi, E., W. Chen, S. Ulaszewsld, E. Capieaux, and A. Goffeau. 1987. The multiple drug resistance gene PDR1 from Saccharomyces cerevisiae. J. Biol. Chem. 262:16871–16879.
   PubMed Web of Science ®Google Scholar
• Balzi, E., and A. Goffeau. 1991. Multiple or pleiotropic drug resistance in yeast. Biochim. Biophys. Acta 1073:241–252.
   PubMedGoogle Scholar
• Berger, S. L., W. D. De Cress, A. Cress, S. J. Triezenberg, and L. Guarente. 1990. Selective inhibition of activated but not basal transcription by the acidic activation domain of VP16: evidence for transcriptional adaptors. Cell 61:1199–1208.
   PubMed Web of Science ®Google Scholar
• Berger, S. L., B. Pina, N. Silverman, G. A. Marcus, J. Agapite, J. L. Regier, S. J. Triezenberg, and L. Guarente. 1992. Genetic isolation of ADA2: a potential transcriptional adaptor required for function of certain acidic activation domains. Cell 70:251–265.
   PubMed Web of Science ®Google Scholar
• Bradford, Μ. Μ. 1976. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248–254.
   PubMed Web of Science ®Google Scholar
• Chevalier, Μ. R., J.-C. Block, and F. Lacroute. 1980. Transcriptional and translational expression of a chimeric bacterial-yeast plasmid in yeasts. Gene 11:11–19.
   PubMed Web of Science ®Google Scholar
• Cress, W. D., and S. J. Triezenberg. 1991. Critical structural elements of the VP16 transcriptional activation domain. Science 251:87–90.
   PubMedGoogle Scholar
• Dynlacht, B. D., T. Hoey, and R. Tjian. 1991. Isolation of coactivators associated with the TATA-binding protein that mediate transcriptional activation. Cell 66:563–575.
   PubMedGoogle Scholar
• Eilers, M., D. Picard, K. R. Yamamoto, and J. Μ. Bishop. 1989. Chimearas of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature (London) 340:66–68.
   PubMedGoogle Scholar
• Elliston, J. F., S. Y. Tsai, B. W. O'Malley, and Μ. Tsai. 1990. Superactive estrogen receptors. J. Biol. Chem. 265:11517–11521.
   PubMedGoogle Scholar
• Erhart, E., and C. P. Hollenberg. 1983. The presence of a defective LEU2 gene on 2μ DNA recombinant plasmids of Saccharomyces cerevisiae is responsible for curing and high copy number. J. Bacteriol. 156:625–635.
   PubMed Web of Science ®Google Scholar
• Gilbert, D. Μ., and Y. Lemoine. Unpublished data.
   Google Scholar
• Gill, G., and Μ. Ptashne. 1988. Negative effect of the transcriptional activator GAL4. Nature (London) 334:721–724.
   PubMed Web of Science ®Google Scholar
• Green, S., I. Issemann, and E. Scheer. 1988. A versatile in vivo and in vitro eukaryotic expression vector for protein engineering. Nucleic Acids Res. 16:369.
   PubMedGoogle Scholar
• Heery, D. Μ., and Y. Lemoine. Unpublished data.
   Google Scholar
• Hovlan, P., J. Flick, Μ. Johnston, and R. A. Sclafani. 1989. Galactose as a gratuitous inducer of GAL gene expression in yeasts growing on glucose. Gene 83:57–64.
   PubMedGoogle Scholar
• Kalderon, D., B. L. Roberts, W. D. Richardson, and A. E. Smith. 1984. A short amino acid sequence able to specify nuclear location. Cell 39:499–509.
   PubMed Web of Science ®Google Scholar
• Kambadur, R., V. Culotta, and D. Hamer. 1990. Cloned yeast and mammalian transcription factor TFIID gene products support basal but not activated metallothionein gene transcription. Proc. Natl. Acad. Sci. USA 87:9168–9172.
   PubMedGoogle Scholar
• Kelleher, R. J., III, P. Μ. Flanagan, and R. Kornberg. 1990. A novel mediator between activator proteins and the RNA polymerase II transcription apparatus. Cell 61:1209–1215.
   PubMed Web of Science ®Google Scholar
• Kilmartin, J. V., and A. E. Adams. 1984. Structural rearrangements of tubulin and actin during the cell cycle of the yeast Saccharomyces. J. Cell Biol. 98:922–933.
   PubMed Web of Science ®Google Scholar
• Kumar, V., and P. Chambon. 1988. The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 55:145–156.
   PubMed Web of Science ®Google Scholar
• Kumar, V., S. Green, G. Stack, Μ. Berry, J. R. Jin, and P. Chambon. 1987. Functional domains of the human estrogen receptor. Cell 51:941–951.
   PubMed Web of Science ®Google Scholar
• Lewin, B. 1990. Commitment and activation at PolII promoters. Cell 61:1161–1164.
   PubMed Web of Science ®Google Scholar
• Loison, G., A. Findeli, S. Bernard, Μ. Nguyen-Juilleret, Μ. Marquet, N. Riehl-Bellon, D. Carvallo, L. Guerra-Santos, S. Brown, Μ. Courtney, C. Roitsch, and Y. Lemoine. 1988. Expression and secretion in S. cerevisiae of biologically active leech hirudin. Bio/Technology 6:72–77.
   Web of Science ®Google Scholar
• Loison, G., R. Losson, and F. Lacroute. 1980. Constitutive mutants for orotidine-5' -phosphate decarboxylase and dihydro-orotic acid dehydrogenase in Saccharomyces cerevisiae. Curr. Genet. 2:103–107.
   PubMedGoogle Scholar
• Loison, G., A. Vidal, A. Findeli, C. Roitsch, J. Μ. Balloul, and Y. Lemoine. 1989. High level expression of a protective antigen of schistosomes in Saccharomyces cerevisiae. Yeast 5:497–507.
   PubMedGoogle Scholar
• Losson, R. Unpublished data.
   Google Scholar
• Mak, P., D. P. McDonnell, N. L. Weigel, W. Schrader, and B. O’Malley. 1989. Expression of functional chicken oviduct progesterone receptors in yeast. J. Biol. Chem. 264:21613–21618.
   PubMedGoogle Scholar
• Martin, K. J., J. W. Lulie, and Μ. R. Green. 1990. Evidence for interaction of different eukaryotic transcriptional activators with distinct cellular targets. Nature (London) 346:147–152.
   PubMedGoogle Scholar
• Metzger, D., J. H. White, and P. Chambón. 1988. The human oestrogen receptor functions in yeast. Nature (London) 334:31–36.
   PubMed Web of Science ®Google Scholar
• Meyer, Μ. E., M. Gronemeyer, B. Turcotte, Μ. T. Bocquel, D. Tasset, and P. Chambon. 1989. Steroid hormone receptors compete for factors that mediate their enhancer function. Cell 57:433–442.
   PubMed Web of Science ®Google Scholar
• Miller, J. H. 1972. Experiments in molecular genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
   Google Scholar
• Murray, J., Μ. Scarpa, N. Rossi, and G. Cesareni. 1987. Antagonistic controls regulate copy number of the yeast 2μ plasmid. EMBO J. 6:4205–4212.
   PubMedGoogle Scholar
• Peterson, Μ. G., N. Tanese, B. F. Pugh, and R. Tjian. 1990. Functional domains and upstream activation properties of cloned human TATA binding protein. Science 248:1625–1630.
   PubMedGoogle Scholar
• Picard, D., S. J. Salser, and K. R. Yamamoto. 1988. A movable and regulable inactivation function within the steroid binding domain of the glucocorticoid receptor. Cell 54:1073–1080.
   PubMed Web of Science ®Google Scholar
• Pierrat, B., D. H. Heery, Y. Lemoine, and R. Losson. 1992. Functional analysis of the human estrogen receptor using a phenotypic transactivation assay in yeast. Gene 119:237–245.
   PubMedGoogle Scholar
• Pugh, B. F., and R. Tjian. 1990. Mechanism of transcriptional activation by SPI: evidence for coactivators. Cell 61:1187–1197.
   PubMed Web of Science ®Google Scholar
• Sadowski, I., J. Ma, S. Triezenberg, and Μ. Ptashne. 1988. GAL4-VP16 is an unusually potent transcriptional activator. Nature (London) 335:563–565.
   PubMed Web of Science ®Google Scholar
• Tasset, D., L. Tora, C. Fromental, E. Scheer, and P. Chambon. 1990. Distinct classes of transcriptional activating domains function by different mechanisms. Cell 62:1177–1187.
   PubMed Web of Science ®Google Scholar
• Thukeral, S. K., Μ. L. Morrison, and E. T. Young. 1991. Alanine scanning site-directed mutagenesis of the zinc fingers of transcription factor ADR1: residues that contact DNA and that transactivate. Proc. Natl. Acad. Sci. USA 88:9188–9192.
   PubMedGoogle Scholar
• Tora, L., J. White, C. Brou, D. Tasset, N. Webster, E. Scheer, and P. Chambon. 1989. The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell 59:477–487.
   PubMed Web of Science ®Google Scholar
• Triezenberg, S. J., R. C. Kingsbury, and S. L. McKnight. 1988. Functional dissection of VP16, the trans-activator of herpes simplex immediate early gene expression. Genes Dev. 2:718–729.
   PubMed Web of Science ®Google Scholar
• Vickers, P. J., R. B. Dickson, R. Shoemaker, and K. Cowan. 1988. A multidrug-resistant MCF-7 human breast cancer cell line which exhibits cross-resistance to antiestrogens and hormone-independent tumor growth in vivo. Mol. Endocrinol. 2:886–892.
   PubMed Web of Science ®Google Scholar
• Wada, T., Y. Nogi, H. Handa, and T. Fukasawa. 1990. Strain specific lethal effect of the adenovirus Ela protein on Saccharomyces cerevisiae. Biophys. Biochem. Res. Commun. 170:470–476.
   PubMedGoogle Scholar
• Webster, L. C., and R. P. Ricciardi. 1991. trans-dominant mutants of Ela provide genetic evidence that the zinc finger of the trans-activating domain binds a transcription factor. Mol. Cell. Biol. 11:4287–4296.
   PubMedGoogle Scholar
• West, R. W., R. R. Yocum, and Μ. Ptashne. 1984. Saccharomyces cerevisiae GAL1-GAL10 divergent promoter region: location and function of the upstream activating sequence UASg Mol. Cell. Biol. 4:2467–2478.
   Google Scholar
• White, J. H., C. Brou, J. Wu, N. Burtow, J. Μ. Egly, and P. Chambon. 1991. Evidence for a factor required for transcriptional stimulation by GAL4-VP16 in HeLa cell extracts. Proc. Natl. Acad. Sci. USA 88:7674–7678.
   PubMedGoogle Scholar
• Wolcott, J. H., and C. Ross. 1966. Orotidine-5,-phosphate decarboxylase from higher plants. Biochim. Biophys. Acta 122:532–534.
   Google Scholar
• Wright, A. P. H., I. J. McEwan, K. Dahiman-Wright, and J. Gustafsson. 1991. High level expression of the major transactivation domain of the human glucocorticoid receptor in yeast cells inhibits endogenous gene expression and cell growth. Mol. Endocrinol. 5:1366–1372.
   PubMedGoogle Scholar